Insights

Loading spinner
Gathering insights about OrsoBio

OrsoBio Tech Stack

OrsoBio uses 8 technology products and services including WordPress, Open Graph, Google Fonts API, and more. Explore OrsoBio's tech stack below.

  • WordPress
    Content Management System
  • Open Graph
    Content Management System
  • Google Fonts API
    Font Scripts
  • Font Awesome
    Font Scripts
  • jQuery
    Javascript Libraries
  • Elementor
    Page Builders
  • SiteGround
    Platform As A Service
  • Google Tag Manager
    Tag Management

Media & News

OrsoBio's Email Address Formats

OrsoBio uses at least 1 format(s):
OrsoBio Email FormatsExamplePercentage
FLast@orsobio.comJDoe@orsobio.com
52%
First@orsobio.comJohn@orsobio.com
34%
Middle@orsobio.comMichael@orsobio.com
9%
First.Last@orsobio.comJohn.Doe@orsobio.com
5%

Frequently Asked Questions

Where is OrsoBio's headquarters located?

Minus sign iconPlus sign icon
OrsoBio's main headquarters is located at Palo Alto, California United States. The company has employees across 1 continents, including North America.

What is OrsoBio's official website and social media links?

Minus sign iconPlus sign icon
OrsoBio's official website is orsobio.com and has social profiles on LinkedInCrunchbase.

What is OrsoBio's SIC code NAICS code?

Minus sign iconPlus sign icon
OrsoBio's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does OrsoBio have currently?

Minus sign iconPlus sign icon
As of March 2026, OrsoBio has approximately 19 employees across 1 continents, including North America. Key team members include Chief Medical Officer And Head Of Development: R. M.Vice President Finance And Controller: A. N.Vice President, Clinical Development & Operations: S. H.. Explore OrsoBio's employee directory with LeadIQ.

What industry does OrsoBio belong to?

Minus sign iconPlus sign icon
OrsoBio operates in the Biotechnology Research industry.

What technology does OrsoBio use?

Minus sign iconPlus sign icon
OrsoBio's tech stack includes WordPressOpen GraphGoogle Fonts APIFont AwesomejQueryElementorSiteGroundGoogle Tag Manager.

What is OrsoBio's email format?

Minus sign iconPlus sign icon
OrsoBio's email format typically follows the pattern of FLast@orsobio.com. Find more OrsoBio email formats with LeadIQ.

How much funding has OrsoBio raised to date?

Minus sign iconPlus sign icon
As of March 2026, OrsoBio has raised $67M in funding. The last funding round occurred on Sep 06, 2024 for $67M.

When was OrsoBio founded?

Minus sign iconPlus sign icon
OrsoBio was founded in 2021.

OrsoBio

Biotechnology ResearchCalifornia, United States11-50 Employees

OrsoBio, Inc. is a privately held, clinical-stage biopharmaceutical company dedicated to developing therapies to treat severe metabolic disorders, including type 2 diabetes, severe dyslipidemias, lipodystrophies, and nonalcoholic steatohepatitis. OrsoBio currently has four programs in clinical and preclinical development with first-in-class compounds that address central pathways in energy metabolism.

Section iconCompany Overview

Headquarters
Palo Alto, California United States
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2021
Employees
11-50

Section iconFunding & Financials

  • $67M

    OrsoBio has raised a total of $67M of funding over 3 rounds. Their latest funding round was raised on Sep 06, 2024 in the amount of $67M.

  • $1M$10M

    OrsoBio's revenue is estimated to be in the range of $1M$10M

Section iconFunding & Financials

  • $67M

    OrsoBio has raised a total of $67M of funding over 3 rounds. Their latest funding round was raised on Sep 06, 2024 in the amount of $67M.

  • $1M$10M

    OrsoBio's revenue is estimated to be in the range of $1M$10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.